We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Pfizer said Wednesday that it entered into a definitive agreement to acquire all of the shares of Therachon for $340 million upfront, with a further $470 million in milestone payments linked to ...
An experimental drug has shown promise in extending the lives of women suffering from a particularly aggressive and deadly type of breast cancer, according to the results of a phase 2 trial....